8-K
Current Report
Stoke Therapeutics, Inc. Filed Acc 0001193125-25-028650
Material agreement · Regulation FD disclosure · Other events
- Item 1.01 Entry into a material definitive agreement
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading d889348d8k.htm…